Increasing evidence suggests that SCFAs may have a beneficial role in adipose tissue, skeletal muscle and liver substrate metabolism, thereby contributing to improved insulin sensitivity and decrease in obesity 14, 15, 21. This evidence concerns the gene INS and obesity disorder.